Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
Guidance Documents/Guidance-Document/Psychedelic Drugs: Considerations for Clinical Investigations

Psychedelic Drugs: Considerations for Clinical Investigations

Detailed guidance document from FDA and regulatory agencies.

Document Details

Guidance Document

June 23, 2023

June 26, 2023

Center for Drug Evaluation and Research

c22c8005-efa9-4373-893d-cf27911562b6

Related Documents

Clinical Pharmacology Considerations for Peptide Drug Products

Guidance DocumentDecember 14, 2023Center for Drug Evaluation and Research
View Details →

Migraine: Developing Drugs for Preventive Treatment

Guidance DocumentJune 1, 2023Center for Drug Evaluation and Research
View Details →

Opioid Analgesic Drugs: Considerations for Benefit-Risk Assessment Framework Guidance for Industry

Guidance DocumentJune 20, 2019Center for Drug Evaluation and Research
View Details →

Quick Actions

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.

KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.